13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001471085
Total reported value
$931.1M
$931.1M
43 檔
61.4%
During the Q4 2025 filing period, Bronte Capital Management Pty Ltd. (CIK: 0001471085) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $931.1M across 43 reported positions.
Bronte Capital Management Pty Ltd. executed strategic sector rebalancing during Q4 2025, establishing 16 new positions while fully exiting 3 holdings and trimming 22 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 18.17% | -2.98% | +30.94% | |
| 2 | GOOGL | Alphabet Inc-cl A | Stock-Comm Services | 12.99% | +0.85% | -2.62% | |
| 3 | IBKR | Interactive Brokers Gro-cl A | Stock-Financials | 9.53% | -0.25% | -15.61% | |
| 4 | ✓ | Visa Inc-class A Shares | Stock-Other | 8.23% | +0.94% | -0.30% | |
| 5 | BRK-B | Berkshire Hathaway Inc-cl B | Stock-Other | 8.14% | +0.48% | -7.10% | |
| 6 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 6.39% | +0.80% | -4.68% | |
| 7 | PM | Philip Morris International | Stock-Consumer Staples | 6.38% | +0.25% | -4.57% | |
| 8 | COF | Capital One Financial CORP | Stock-Financials | 4.24% | +0.36% | -33.53% | |
| 9 | CTVA | Corteva Inc | Stock-Materials | 3.80% | -0.02% | -0.35% | |
| 10 | FCNCA | First Citizens Bcshs -cl A | Stock-Financials | 3.65% | +0.09% | -17.21% | |
| 11 | ✓ | Vaneck ETF Trust | ETF-Other | 1.86% | -0.34% | -29.15% | |
| 12 | ALNY | Alnylam Pharmaceuticals Inc | Stock-Healthcare | 1.54% | -0.08% | +11.12% | |
| 13 | ✓ | Sotera Health Co | Stock-Other | 1.54% | +0.32% | -1.19% | |
| 14 | GHC | Graham Holdings Co-class B | Stock-Industrials | 1.46% | +0.06% | -0.31% | |
| 15 | HLF | Herbalife Ltd. | Stock-Other | 1.44% | -0.91% | -17.57% | |
| 16 | PINS | Pinterest Inc- Class A | Stock-Comm Services | 1.32% | -0.78% | EXIT | |
| 17 | TBBB | BBB Foods Inc. | Stock-Other | 1.31% | +0.68% | — | |
| 18 | IBB | Ishares Biotechnology ETF | ETF-Tech | 1.22% | +0.18% | -74.29% | |
| 19 | SQM | Quimica Y Minera Chil-sp Adr | Stock-Other | 1.12% | -0.06% | -0.69% | |
| 20 | SBH | Sally Beauty Holdings Inc | Stock-Other | 1.05% | -0.30% | EXIT | |
| 21 | NEM | Newmont CORP | Stock-Materials | 0.78% | -0.11% | -0.20% | |
| 22 | B | Barrick Mining CORP | Stock-Materials | 0.72% | -0.06% | -22.63% | |
| 23 | RAMP | Liveramp Holdings Inc | Stock-Other | 0.68% | -0.07% | +0.26% | |
| 24 | BBWI | Bath & Body Works Inc | Stock-Consumer Disc | 0.51% | +0.07% | +121.78% | |
| 25 | MDLZ | Mondelez International Inc-a | Stock-Consumer Staples | 0.35% | +0.01% | -2.01% | |
| 26 | ✓ | Vaneck ETF Trust | ETF-Other | 0.32% | -0.06% | -81.60% | |
| 27 | FICO | Fair Isaac CORP | Stock-Tech | 0.26% | — | — | |
| 28 | TPB | Turning Point Brands Inc | Stock-Other | 0.26% | — | — | |
| 29 | RSKD | Riskified Ltd. | Stock-Other | 0.25% | +0.13% | -0.00% | |
| 30 | NICE | Nice LTD - Spon Adr | Stock-Tech | 0.23% | -0.03% | — | |
| 31 | OLED | Universal Display CORP | Stock-Tech | 0.14% | — | — | |
| 32 | JRVR | James River Group Holdings I | Stock-Other | 0.08% | -0.21% | EXIT | |
| 33 | ENVX | Enovix CORP | Stock-Other | 0.01% | — | — | |
| 34 | GUTS | Fractyl Health Inc | Stock-Other | — | — | EXIT | |
| 35 | ALEC | Alector Inc | Stock-Other | — | — | — | |
| 36 | CHRS | Coherus Oncology Inc | Stock-Other | — | — | — | |
| 37 | IVVD | Invivyd Inc | Stock-Other | — | — | EXIT | |
| 38 | CRBU | Caribou Biosciences Inc | Stock-Other | — | — | EXIT | |
| 39 | PLRX | Pliant Therapeutics Inc | Stock-Other | — | — | EXIT | |
| 40 | FATE | Fate Therapeutics Inc | Stock-Other | — | +0.01% | — | |
| 41 | MIST | Milestone Pharmaceuticals In | Stock-Other | — | — | — | |
| 42 | RANI | Rani Therapeutics Holdings-a | Stock-Other | — | — | EXIT | |
| 43 | CCCC | C4 Therapeutics Inc | Stock-Other | — | +0.01% | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | REGN | Regeneron Pharmaceuticals | +8% | +30.94% | Add |
| 2 | GOOGL | Alphabet Inc-cl A | +2.6% | -2.62% | Trim |
| 3 | SQM | Quimica Y Minera Chil-sp Adr | +0.4% | -0.69% | Trim |
| 4 | HLF | Herbalife Ltd. | +0.3% | -17.57% | Trim |
| 5 | BBWI | Bath & Body Works Inc | +0.2% | +121.78% | Add |
| 6 | ✓ | Visa Inc-class A Shares | +0.2% | -0.30% | Trim |
| 7 | ✓ | Sotera Health Co | +0.2% | -1.19% | Trim |
| 8 | NEM | Newmont CORP | +0.1% | -0.20% | Trim |
| 9 | RAMP | Liveramp Holdings Inc | +0.1% | +0.26% | Add |
| 10 | B | Barrick Mining CORP | 0% | -22.63% | Trim |
| 11 | RSKD | Riskified Ltd. | 0% | -0.00% | Trim |
| 12 | ENVX | Enovix CORP | — | — | Unchanged |
| 13 | AMZN | Amazon.com Inc | 0% | -4.68% | Trim |
| 14 | FCNCA | First Citizens Bcshs -cl A | 0% | -17.21% | Trim |
| 15 | CTVA | Corteva Inc | -0.1% | -0.35% | Trim |
| 16 | ALNY | Alnylam Pharmaceuticals Inc | -0.1% | +11.12% | Add |
| 17 | MDLZ | Mondelez International Inc-a | -0.1% | -2.01% | Trim |
| 18 | GHC | Graham Holdings Co-class B | -0.1% | -0.31% | Trim |
| 19 | PM | Philip Morris International | -0.4% | -4.57% | Trim |
| 20 | ✓ | Vaneck ETF Trust | -0.5% | -29.15% | Trim |
| 21 | BRK-B | Berkshire Hathaway Inc-cl B | -0.7% | -7.10% | Trim |
| 22 | SBH | Sally Beauty Holdings Inc | -0.7% | -31.81% | Trim |
| 23 | PINS | Pinterest Inc- Class A | -0.8% | -21.11% | Trim |
| 24 | ✓ | Vaneck ETF Trust | -1.2% | -81.60% | Trim |
| 25 | COF | Capital One Financial CORP | -1.4% | -33.53% | Trim |
| 26 | IBKR | Interactive Brokers Gro-cl A | -2.6% | -15.61% | Trim |
| 27 | IBB | Ishares Biotechnology ETF | -2.9% | -74.29% | Trim |
| 28 | ABVX | Abivax Sa-adr | — | EXIT | Sold out |
| 29 | TBBB | BBB Foods Inc. | — | NEW | New buy |
| 30 | IJR | Ishares Core S&p Small-cap E | — | EXIT | Sold out |
| 31 | IWO | Ishares Russell 2000 Growth | — | EXIT | Sold out |
| 32 | FICO | Fair Isaac CORP | — | NEW | New buy |
| 33 | TPB | Turning Point Brands Inc | — | NEW | New buy |
| 34 | NICE | Nice LTD - Spon Adr | — | NEW | New buy |
| 35 | OLED | Universal Display CORP | — | NEW | New buy |
| 36 | JRVR | James River Group Holdings I | — | NEW | New buy |
| 37 | GUTS | Fractyl Health Inc | — | NEW | New buy |
| 38 | ALEC | Alector Inc | — | NEW | New buy |
| 39 | CHRS | Coherus Oncology Inc | — | NEW | New buy |
| 40 | IVVD | Invivyd Inc | — | NEW | New buy |
| 41 | CRBU | Caribou Biosciences Inc | — | NEW | New buy |
| 42 | PLRX | Pliant Therapeutics Inc | — | NEW | New buy |
| 43 | FATE | Fate Therapeutics Inc | — | NEW | New buy |
| 44 | MIST | Milestone Pharmaceuticals In | — | NEW | New buy |
| 45 | RANI | Rani Therapeutics Holdings-a | — | NEW | New buy |
| 46 | CCCC | C4 Therapeutics Inc | — | NEW | New buy |
According to official SEC Form 13F filings, Bronte Capital Management Pty Ltd. reported a total U.S. public equity portfolio value of $931.1M across 43 disclosed positions in Q4 2025.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including REGN, GOOGL, IBKR) accounted for 61.4% of total reported equity market value during Q4 2025.
Top New Position Initiated
TBBB
市值: $13.2M
Top Position Liquidated / Trimmed
ABVX
前期市值: $14.9M
During Q4 2025, Bronte Capital Management Pty Ltd.'s top holdings by market value included REGN (18.2%)、GOOGL (13.0%)、IBKR (9.5%). The largest single position, REGN, represented 18.2% of total portfolio value.
In Q4 2025, Bronte Capital Management Pty Ltd. made 45 total portfolio adjustments, initiating 16 new buys, adding to 4 positions, trimming 22 holdings, and fully liquidating 3 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.